✦ LIBER ✦

A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy

✍ Scribed by Mary Feng; David E. Smith; Daniel P. Normolle; James A. Knol; Charlie C. Pan; Edgar Ben-Josef; Zheng Lu; Meihua R. Feng; Jun Chen; William Ensminger; Theodore S. Lawrence

Book ID: 118456957
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 377 KB
Volume: 83
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.10.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Tolerability of Physcion in H

Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study

✍ Tzeng, Tsang-Bin ;Chang, Wei-Kuo ;Huang, Tien-Yu ;Wu, Pei-Tzu ;Huang, Wen-Chuan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Toxicity and Efficacy Results From a Pha

Toxicity and Efficacy Results From a Phase I Dose-Escalation Study of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

✍ Meyer, J.J.; Foster, R.; Lev-Cohain, N.; Yokoo, T.; Schwarz, R.; Rule, W.; Solbe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A Clinical phase I/II trial to investiga

A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma

✍ Falk Roeder, Daniela Schulz-Ertner, Anna V Nikoghosyan, Peter E Huber, Lutz Edle 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 183 KB